Physician profile
Carolyn Macuha
NPI 1518592039
$7,681.23
in general payments reported to CMS, 2019-2025
43 companies · $1,698 in 2025
The $1,698 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,088 · 2022: $1,956 · 2023: $2,006 · 2024: $933 · 2025: $1,698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,637.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $952.66 | 2021-2025 | Tepezza, Evenity, Repatha |
| Novo Nordisk INC | $892.40 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Medtronic, INC. | $510.81 | 2021-2025 | Minimed 780g |
| Janssen Biotech, INC. | $454.47 | 2025 | Tremfya, Simponi Aria, Simponi |
| Boston Scientific Corporation | $337.95 | 2023-2025 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $319.84 | 2021-2024 | Farxiga, Brilinta |
| Aimmune Therapeutics, INC. | $306.85 | 2024-2025 | Zenpep, Vowst |
| Esperion Therapeutics, INC. | $272.80 | 2021-2023 | Nexletol |
| Merck Sharp & Dohme LLC | $252.17 | 2023 | Verquvo |
| Mannkind Corporation | $250.00 | 2023 | V-Go |
| Dexcom, INC. | $248.71 | 2022-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Corcept Therapeutics | $239.50 | 2021-2022 | |
| Abbvie INC. | $231.74 | 2021-2025 | |
| Horizon Therapeutics Plc | $226.27 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $224.73 | 2022-2023 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolyn Macuha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.